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Abstract
Background: The early prediction of neurological outcomes in postcardiac arrest patients treated with therapeutic
hypothermia (TH) remains challenging. Amplitude-integrated electroencephalography (aEEG) is a type of
quantitative EEG. A particular cutoff time from the return of spontaneous circulation (ROSC) to the recovery of a
normal aEEG trace for predicting a good neurological outcome has not yet been established. The purpose of the
present study was to examine the relation between neurological outcomes and the continuous normal voltage
(CNV) recovery time in adult comatose survivors of cardiac arrest treated with TH and identify the recovery time
cutoff for predicting a good neurological outcome.
Methods: We retrospectively evaluated adult survivors of cardiac arrest with initial shockable rhythm treated with
TH and monitored with aEEG. A good outcome was defined as a cerebral performance category (CPC) of 1 or 2 at
hospital discharge. A CNV trace was considered as the normal aEEG trace, and the CNV recovery time was defined
as the time from ROSC to the initial CNV trace.
Results: The study included 30 patients, and of these patients, 22 had recovery of CNV trace. The median CNV
recovery time was shorter among patients with a good outcome than that among those with a poor outcome
(10.7 h [interquartile range (IQR), 7.4–15.8 h] vs. 28.6 h [IQR, 26.9–29.3 h]; p = 0.003). The area under the receiver
operating characteristic curve of the CNV recovery time for predicting a good neurological outcome was 0.95
(95 % CI 0.86–1; p = 0.003), and the optimal cutoff was 23 h. The recovery of CNV trace within 23 h had a
sensitivity of 89 %, specificity of 100 %, positive predictive value of 100 %, and negative predictive value of
86 % for predicting a good neurological outcome in all the patients, including the eight patients without
recovery of CNV trace.
Conclusions: A CNV recovery time cutoff of 23 h might help predict a good neurological outcome in adult
survivors of cardiac arrest treated with TH.
Keywords: Amplitude-integrated electroencephalography, Cardiac arrest, Neurological outcome, Therapeutic
hypothermia
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Background
The early prediction of neurological outcomes in postcar-
diac arrest patients treated with therapeutic hypothermia
(TH) remains challenging. Recently, continuous electroen-
cephalography (cEEG) was reported to be useful in the
early prediction of neurological outcomes [1]. However,
special training is required for the interpretation of cEEG
findings. Amplitude-integrated electroencephalography
(aEEG) is a type of quantitative EEG and is derived from
single- or two-channel cEEG recordings. The maximum
and minimum amplitudes within a short period are
displayed as bandwidths along with a compressed time
scale. aEEG findings can be easily interpreted by non-
neurologists, and aEEG findings have already been widely
used to predict neurological outcomes in neonates with
hypoxic-ischemic encephalopathy [2]. Recently, Rundgren
et al. [3] and Oh et al. [4] reported the usefulness of aEEG
for predicting neurological outcomes in adult comatose
survivors of cardiac arrest treated with TH. The recording
channels and pattern classifications of aEEG differed be-
tween these two reports. Rundgren et al. classified aEEG
patterns as follows: continuous, flat trace (FT), burst sup-
pression (BS), and electrical status epilepticus (SE), while
Oh et al. classified aEEG patterns as follows: continuous
normal voltage (CNV), discontinuous normal voltage
(DNV), low voltage (LV), FT, BS, and SE. The classifica-
tion used by Oh et al. is commonly applied in the field of
neonatology and has a more precise voltage criterion than
the classification used by Rundgren et al. The continuous
pattern in the classification used by Rundgren et al. and
the CNV pattern used by Oh et al. were found to provide
the best trace in each classification, which could be con-
sidered as a normal trace for cardiac arrest survivors. Both
these studies showed that the early recovery of this normal
aEEG trace after cardiac arrest predicts a good neuro-
logical outcome. However, a BS pattern and the lack of
recovery of the normal trace within 36–72 h after cardiac
arrest predicted a poor neurological outcome. An initial
FT pattern of aEEG does not necessarily predict a poor
outcome if the normal trace recovers during this initial
period.
Although recovery of the normal aEEG trace is essen-
tial to obtain a good neurological outcome, some pa-
tients who take a long time to achieve recovery of the
normal trace do not have a good neurological outcome.
A particular cutoff time from the return of spontaneous
circulation (ROSC) to the recovery of the normal aEEG
trace for predicting a good neurological outcome has
not yet been established. The purpose of the present
study was to examine the relation between neurological
outcomes and the CNV recovery time in adult comatose
survivors of cardiac arrest treated with TH, and identify




This retrospective study included comatose survivors of
out-of-hospital cardiac arrest aged 18 years or older,
who were admitted to the emergency department of
Tokyo Metropolitan Bokutoh Hospital in Japan and were
treated with TH after successful resuscitation between
January 2013 and December 2014. Patients with initial
non-shockable rhythm were excluded from the study.
Because the present study used aEEG recordings in the
early phase after cardiac arrest, patients in whom aEEG
monitoring was started ≥24 h after ROSC were excluded.
Additionally, patients with a history of neurological dis-
eases or brain injury, and those who died within 72 h
after cardiac arrest were excluded. The baseline demo-
graphic and clinical characteristics of the patients were
collected from medical records, and the timings of pre-
hospital events were recorded according to the reports
of emergency medical service personnel. The institu-
tional review board of Tokyo Metropolitan Bokutoh
Hospital approved the study, and the requirement of in-
formed consent was waived owing to the retrospective
design of the study.
TH protocol
All patients were resuscitated according to the current
recommendations.
Patients who remained comatose (lack of meaningful
responses to verbal commands) after ROSC were treated
with TH at 34 °C for 24 h. Exclusion criteria of TH in-
cluded hemodynamic instability refractory to the use of
vasopressor agents and mechanical support, refractory
ventricular arrhythmia (ventricular fibrillation and sus-
tained ventricular tachycardia), active bleeding, and ter-
minal illness prior to cardiac arrest. TH was started
immediately after admission to the emergency depart-
ment and was applied by using a cooling technique com-
bining the administration of intravenous ice-cold fluids
and the application of a surface cooling device (Arctic
Sun System; Medivance, Louisville, CO). Extracorporeal
cardiopulmonary resuscitation (ECPR) was performed in
witnessed cardiac arrest patients with initial shockable
rhythm, who were aged ≤65 years, if cardiac arrest
sustained and was refractory to conventional advanced
life support procedures after hospital arrival. Exclu-
sion criteria of ECPR included the prolonged cardiac
arrest ≥30 min before hospital arrival and terminal illness
prior to cardiac arrest. In these patients, a heat exchanger
was used in the circuit to control body temperature.
Bladder temperature was used for temperature man-
agement. Midazolam (0.05–0.1 mg/kg/h) and fentanyl
(1 μg/kg/h) were administered for sedation and anal-
gesia, and vecuronium (0.05–0.1 mg/kg/h) was admin-
istered to control shivering. After completion of 24 h
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of TH, patients were rewarmed at the rate of 0.15 °C/h
until the body temperature reached 36 °C, and then, mid-
azolam and vecuronium were discontinued.
aEEG data
All patients were monitored with aEEG (NicoletOne;
Viasys Healthcare, Madison, WI) after admission to the
intensive care unit. The cup electrodes were attached
across the forehead at positions Fp1 and Fp2, and aEEG
monitoring was performed for the bipolar channel Fp1-
Fp2 (Fig. 1).
We applied the classification system of aEEG patterns
used by Oh et al. (Fig. 2) [4], and a CNV trace was con-
sidered the normal trace in both pattern and voltage
criteria.
The CNV recovery time was defined as the time from
ROSC to the initial recoding of a CNV trace (maximum
amplitude >10 μV; minimum amplitude >5 μV) on aEEG
with a time scale of 6 cm/h. The CNV recovery time
was examined in all patients with a CNV trace on aEEG.
In patients with a CNV trace at the start of aEEG moni-
toring, the CNV recovery time was defined as the time
from ROSC to the start of aEEG monitoring.
Neurological outcome assessment
The cerebral performance category (CPC) scale was used
to assess neurological outcomes on the day of hospital
discharge, and the data were extracted from the medical
records. The neurological outcome was considered good
if the CPC was 1 or 2, and poor if the CPC was 3–5 [5].
Statistical analysis
Continuous variables are reported as medians with inter-
quartile ranges (IQRs), and dichotomous variables are
reported as numbers with percentages. Univariate com-
parisons of the outcomes were performed using the
Fisher exact test for categorical variables and the Mann-
Whitney U test for continuous variables. The optimal
CNV recovery time cutoff for predicting a good neuro-
logical outcome was determined using the Youden
index. The ability to predict the neurological outcome
was assessed according to sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV),
and area under the receiver operating characteristic
curve (AUROC). All statistical analyses were performed
using EZR (Saitama Medical Center, Jichi Medical
University, Saitama, Japan), which is a graphical user inter-
face for R (The R Foundation for Statistical Computing,
Vienna, Austria) [6].
Results
During the study period, 70 out-of-hospital cardiac ar-
rest patients were treated with TH. Of these patients, 48
were monitored with aEEG. However, 12 with initial
non-shockable rhythm, two who died within 72 h after
cardiac arrest, and four without aEEG monitoring in the
first 24 h after ROSC were excluded. Therefore, 30 pa-
tients were finally included in the study (Fig. 3). Of the
30 patients, 27 (90 %) were male. The median age of the
patients was 62 years (IQR, 45–71 years), and 26 (87 %)
patients had a witnessed collapse. The median time from
collapse to ROSC was 22 min (IQR, 18–40 min). The
median time from collapse to the start of aEEG monitor-
ing was 6.8 h (IQR, 4.8–8.5 h), and the median duration
of aEEG monitoring was 50 h (IQR, 45–63 h). A total of
four (13 %) patients received ECPR. Of the 30 patients,
18 (60 %) had a good outcome and 12 (40 %) had a poor
outcome. The median age was significantly lower among
patients with a good outcome than among those with a
poor outcome (47 years [IQR, 43–66 years] vs. 70 years
[IQR, 62–72 years]; p = 0.01). Additionally, the median
time from collapse to ROSC was significantly shorter
among patients with a good outcome than among those
with a poor outcome (19 min [IQR, 14–22 min] vs.
44 min [IQR, 30–47 min]; p < 0.001). Moreover, the pro-
portion of patients who received ECPR was significantly
lower among patients with a good outcome than among
those with a poor outcome (0 vs. 33 %; p = 0.02). Fur-
thermore, the median time from collapse to the target
temperature was significantly longer among patients
with a good outcome than among those with a poor out-
come (6.1 h [IQR, 5.3–8.0 h] vs. 4.0 h [IQR, 1.3–5.7 h];
p = 0.02). Other variables were comparable between pa-
tients with a good outcome and those with a poor out-
come (Table 1). At discharge, 18 (60 %) patients had a
Fig. 1 Placement of electrodes for amplitude-integrated
electroencephalography (aEEG) monitoring. Cup electrodes are
attached at positions Fp1 and Fp2, and aEEG monitoring was
performed for the bipolar channel Fp1-Fp2
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CPC of 1 or 2, six (20 %) had a CPC of 3 or 4, and six
(20 %) had a CPC of 5 (died in hospital). The median
duration of hospital stay was 24 days (IQR, 12–41 days)
among all the patients, 22 days (IQR, 13–34 days)
among those with a good outcome, and 42 days (IQR,
5–56 days) among those with a poor outcome.
As the initial trace, eight patients had CNV trace,
three had DNV, seven had LV, one had BS, one had SE,
and 10 had FT. All the eight patients of initial CNV
trace, two of DNV, five of LV, and three of FT had a
good neurological outcome. During aEEG monitoring,
22 patients had recovery of CNV trace, and of these pa-
tients, 17 (77 %) had a good neurological outcome. Add-
itionally, of the 22 patients, eight had CNV trace as the
initial trace, two had DNV, five had LV, one had SE, and
six had FT. In this group of patients who had recovery of
CNV trace, the median CNV recovery time was shorter
among patients with a good outcome than among those
with a poor outcome (10.7 h [IQR, 7.4–15.8 h] vs. 28.6 h
[IQR, 26.9–29.3 h]; p = 0.003) (Fig. 4). The AUROC of the
CNV recovery time for predicting a good neurological
outcome was 0.95 (95 % CI 0.86–1; p = 0.003), and the
optimal recovery time cutoff was 23 h (Fig. 5).
Fig. 2 Classification system of the patterns of amplitude-integrated electroencephalography traces used in the study
Fig. 3 Flow chart of patient selection. aEEG amplitude-integrated
electroencephalography, CNV continuous normal voltage
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In all the 30 patients, including the eight patients
without recovery of CNV trace, the recovery of CNV
trace within 23 h could predict a good neurological out-
come, with a sensitivity of 89 %, specificity of 100 %,
PPV of 100 %, and NPV of 86 % (Table 2).
Discussion
The present study found that the CNV recovery time is
useful for predicting neurological outcomes in comatose
survivors of cardiac arrest treated with TH and that the
optimal CNV recovery time cutoff for predicting a good
neurological outcome was 23 h.
After severe brain ischemia, EEG readings are initially
suppressed and recover gradually. Thoresen et al. [7]
reported that the time to a normal aEEG trace was a
good predictor of neurological outcomes in infants with
asphyxia. Our study showed that this is also true in adult
postcardiac arrest patients.
Several factors, such as hypothermia, sedation, and the
method of aEEG recording, should be considered in the
evaluation of the CNV recovery time. EEG has been
reported to not be significantly affected at a body
temperature of 32–34 °C [8]. Midazolam is a sedative
that is widely used during TH, and it has been reported
to cause an increase in beta activity on EEG [9].
Table 1 Comparison of patient characteristics between patients with good and poor neurological outcomes
All patients (n = 30) Good outcome (n = 18) Poor outcome (n = 12) p value
Age (years)a 62 (45–71) 47 (43–66) 70 (62–72) 0.01b
Male, number (%) 27 (90 %) 15 (83 %) 12 (100 %) 0.26c
Witnessed collapse 26 (87 %) 16 (89 %) 10 (83 %) 1c
Time from collapse to
ROSC (min)a 22 (18–40) 19 (14–22) 44 (30–47) <0.001b
Target temperature (h)a 5.5 (4.2–6.7) 6.1 (5.3–8.0) 4.0 (1.3–5.7) 0.02b
aEEG monitoring (h)a 6.8 (4.8–8.5) 6.1 (4.7–8.2) 6.9 (5.3–9.3) 0.35b
Duration of aEEG monitoring (h)a 50 (45–63) 53 (46–58) 47 (45–68) 0.90b
Coronary angiography, number (%) 28 (93 %) 17 (94 %) 11 (92 %) 1c
ECPR, number (%) 4 (13 %) 0 (0 %) 4 (33 %) 0.02c





Fig. 4 Recovery time of CNV between patients with good outcomes
and those with poor outcomes. The CNV recovery time is presented
as median (interquartile range). The Mann-Whitney U test was used
for the comparison. CNV continuous normal voltage
Fig. 5 ROC curve of the CNV recovery time to predict a good
neurological outcome. ROC receiver operating characteristic,
CNV continuous normal voltage, AUROC area under the receiver
operating characteristic curve, CI confidence interval
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Additionally, midazolam can decrease the voltage of
aEEG recordings in neonates [10]. Moreover, in critically
ill adult patients, midazolam can attenuate the voltage of
EEG [11]. In our study, midazolam was infused accord-
ing to body weight; therefore, the effect of midazolam
on the amplitude of EEG would be relatively uniform in
all patients. However, if high doses of midazolam or
other sedatives, such as propofol and barbiturates, are
administered during TH, the CNV recovery time cutoff
for predicting a good neurological outcome may differ
from that identified in the present study. Additionally, in
older patients or those with multiple organ dysfunctions,
the CNV recovery time may be prolonged owing to de-
layed metabolism or excretion of drugs, or the effect of
metabolic encephalopathy. Therefore, a long CNV re-
covery time does not necessarily exclude the possibility
of a good neurological outcome. In our study, a patient
with a CNV recovery time of 35 h had a good neuro-
logical outcome. On the other hand, few factors have
been reported to shorten the CNV recovery time. There-
fore, a short CNV recovery time is strongly associated
with a good neurological outcome, with a high specificity
and PPV. We believe that the CNV recovery time should
be used as a predictor of good neurological outcome in
comatose survivors of cardiac arrest. However, the possi-
bility of alpha coma should be considered when we
evaluate patients with short CNV recovery time. Alpha
coma without reactivity to stimuli has been reported to
be associated with a poor neurological outcome [12],
and the aEEG trace may be classified as a CNV pattern
in patients experiencing alpha coma. Although no pa-
tient had alpha coma in the present study and the pre-
cise frequency of alpha coma in postcardiac patients is
not known, alpha coma can lower the specificity and
PPV of the CNV recovery time to predict a good neuro-
logical outcome.
The method of aEEG has not been standardized in
adult postcardiac arrest patients. Needle electrodes are
not popular in Japan; therefore, we used cup electrodes
in the present study. The cup electrodes were placed
across the forehead, and a bipolar frontal channel was
used for aEEG monitoring. In the study by Rundgren et
al. [3], the bipolar channels F3-P3 and F4-P4 were used;
however, frontal channels are easier to place, less likely
to detach from the forehead, and more suitable for use
in postcardiac arrest patients when cup electrodes are
used. Physicians can attach these cup electrodes easily
within a short period. Focal seizures may not be
recorded with frontal channels alone; however, the mon-
itoring of global cerebral activity is possible with frontal
channels alone in postcardiac arrest patients [4].
The classifications used by Rundgren et al. [3] and Oh
et al. [4] differed. However, both classifications can be
easily applied by non-neurologists. The classification sys-
tem used by Oh et al. has a more precise voltage criteria
and it adopts CNV, DNV, and LV to further classify the
continuous pattern in the classification system used by
Rundgren et al. In the study by Oh et al., the specificity
and PPV of the initial aEEG trace to predict a good
neurological outcome were higher with the voltage
method than with the pattern method alone. Therefore,
we applied the classification system used by Oh et al.
and considered a CNV trace as the normal trace in order
to obtain a high specificity and PPV.
In comatose survivors of cardiac arrest treated with
TH, some reliable predictors of a poor neurological out-
come have been reported [13], which help physicians
avoid providing futile treatment. However, predictors of
a good neurological outcome with a high specificity are
scarce. If a good neurological outcome can be predicted
at the early phase after cardiac arrest, physicians can
select patients having the potential of neurological re-
covery for invasive and advanced treatments that have a
high cost. Therefore, the use of the CNV recovery time
cutoff can help in the appropriate treatment of postcar-
diac arrest patients.
Limitations
The present study has several limitations. First, this was
a retrospective study performed at a single center, with a
small sample size. The timing of the start of aEEG moni-
toring and the duration of monitoring were not deter-
mined previously. Several patients had a CNV trace at
the start of monitoring; therefore, the actual median
CNV recovery time of patients with a good outcome
may have been overestimated. However, this does not
affect the CNV recovery time cutoff. Second, physicians
were not blinded to the aEEG results during treatment.
Although the aEEG results were not used to determine
withdrawal of therapy, the aEEG results might have in-
fluenced therapy selection. Third, the CPC was deter-
mined at discharge, and recovery after discharge was not
Table 2 Sensitivity, specificity, PPV, and NPV of the CNV recovery time cutoff of 23 h
Good outcome (n) Poor outcome (n) Sensitivity (95 % CI) Specificity (95 % CI) PPV (95 % CI) NPV (95 % CI)
CNV recovery time ≤23 h 16 0 89 (65–97) 100 (64–100) 100 (71–100) 86 (57–98)
CNV recovery time >23 h or
no CNV trace
2 12
CNV continuous normal voltage, PPV positive predictive value, NPV negative predictive value, CI confidence interval
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considered. Additionally, the patients who died within
72 h after cardiac arrest were excluded because neuro-
logical outcomes could not be conclusively assessed in
these patients. Six patients died in the hospital in the
present study, and they were included in the poor out-
come group. Among these six patients, five showed dif-
fuse brain swelling or loss of white and gray matter on
head CT and one remained comatose without motor re-
sponse to stimuli and died from sudden circulatory col-
lapse on day 5 (3 days after normothermia). Fourth, the
present study only included patients with initial shock-
able rhythm in order to unify the sample conditions.
Survivors of cardiac arrest with initial non-shockable
rhythm were excluded as prognoses have been reported
to differ between patients with initial shockable and
those with non-shockable rhythm [14, 15]. These pa-
tients should be evaluated separately in future studies.
Conclusions
Neurological outcomes might be related with the CNV
recovery time, and a CNV recovery time cutoff of 23 h
might help predict a good neurological outcome in
comatose survivors of cardiac arrest with initial shock-
able rhythm who are treated with TH.
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